When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - ViiV Healthcare files European application for HIV doublet therapy
Pfizer Inc.
ViiV Healthcare has filed a marketing application in Europe seeking approval for the combination of cabotegravir and Johnson & Johnson (JNJ-0.2%) unit Janssen Therapeutics' rilpivirine, administered via monthly injection, for the treatment of HIV-1 infection in adults with suppressed viral load who are not resistant to either drug.
More news on: Johnson & Johnson, GlaxoSmithKline plc, Pfizer Inc., Healthcare stocks news,